1
|
Sheraba NS, Hesham A, Fawzy M, Diab E, Basuony ME, Yassin AS, Zedan HH, Abu-Elghait M. Advanced approaches for endotoxin detection and removal from snake antivenoms. Toxicon 2023; 222:107003. [PMID: 36535530 DOI: 10.1016/j.toxicon.2022.107003] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Revised: 12/06/2022] [Accepted: 12/13/2022] [Indexed: 12/23/2022]
Abstract
A comprehensive assessment of the literature on strategies for the detection and removing endotoxin from biotechnological preparations was conducted. This study highlighted the brief history of endotoxin. After that, a review of endotoxin's chemical and physical features, as well as its pathophysiological consequences when the body is exposed to LPS excessively or systemically, is presented. The procedures for determining endotoxin and the interaction of endotoxin with proteins are also discussed, considering both known approaches and cutting-edge technology in this sector. This review presented the endotoxin detection and removal approaches from antisera with an economical approach using several processes documented in the literature (e.g., adsorption, ultrafiltration, and chromatography). Different methods with relatively high protein recoveries are mentioned. This review concludes that heat activation at 70 °C-80 °C for 10 min and rehydration of the LAL reagent with endotoxin-specific buffer solution is the best technique to control the enhancement problem when testing polyvalent snake venom antiserum samples by the LAL method. The most efficient method for eliminating endotoxins has proven to be affinity resin-based chromatography.
Collapse
Affiliation(s)
- Norhan S Sheraba
- VACSERA, The Holding Company for Biological Products and Vaccines, Giza, Egypt
| | - Ahmed Hesham
- Department of Chemistry, Faculty of Science, Suez Canal University, Ismailia, 41522, Egypt; Middle East for Vaccines (MEVAC), El-Salihya El-Gededa, El-Sharkia, 44671, Egypt
| | - Mohamed Fawzy
- Department of Virology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, 41522, Egypt
| | - Emad Diab
- Middle East for Vaccines (MEVAC), El-Salihya El-Gededa, El-Sharkia, 44671, Egypt; Department of Infectious Diseases, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt
| | - Mohamad E Basuony
- Middle East for Vaccines (MEVAC), El-Salihya El-Gededa, El-Sharkia, 44671, Egypt; Department of Microbiology, Faculty of Science, Al-Azhar University, Assiut, 71524, Egypt
| | - Aymen S Yassin
- Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
| | - Hamdallah H Zedan
- Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
| | - Mohammed Abu-Elghait
- Department of Botany and Microbiology, Faculty of Science, Al-Azhar University, 11884, Cairo, Egypt.
| |
Collapse
|
2
|
The impact of endotoxin masking on the removal of endotoxin during manufacturing of a biopharmaceutical drug product. J Chromatogr A 2022; 1671:462995. [DOI: 10.1016/j.chroma.2022.462995] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2021] [Revised: 03/18/2022] [Accepted: 03/24/2022] [Indexed: 11/24/2022]
|
3
|
Li P, Yip H, Sun D, Kempson J, Caceres-Cortes J, Mathur A, Wu DR. Sub/supercritical Fluid Chromatography Purification and Desalting of a Cyclic Dinucleotide STING Agonist. J Chromatogr A 2021; 1652:462356. [PMID: 34218126 DOI: 10.1016/j.chroma.2021.462356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Revised: 06/10/2021] [Accepted: 06/14/2021] [Indexed: 10/21/2022]
Abstract
An efficient and "endotoxin-free" purification of a cyclic dinucleotide (CDN) STING agonist was achieved to produce multigram quantities of pure BMT-390025, an active pharmaceutical ingredient (API), for toxicological studies. A two-step sub/supercritical fluid chromatography (SFC) procedure was developed for the achiral purification and desalting of the polar ionic CDN. A robust SFC process employing methanol-acetonitrile-water with ammonium acetate as co-solvent in CO2 on BEH 2-ethylpyridine was established and scaled up as the first step to achieve a successful purification. The desalting/salt-switching (i.e. removing acetate and acetamide) was conducted using methanol-water with ammonium hydroxide as co-solvent on the same column in the second step to convert the final API to the ammonium salt. Water with additive was essential to eliminating salt precipitation and improving the peak shape and resolution. Due to the extreme hydrophilicity of BMT-390025, 65% of co-solvent was needed to adequately elute the target in both steps. More than 40 g of crude API was purified and desalted producing >20 g of pure BMT-390025 as the ammonium salt which was obtained with a chemical purity of >98.5% and met the endotoxin requirement of <0.1 EU/mg. In addition, >80 g of its penultimate prior to the deprotection of the silyl group was purified at a high throughput of 6.3 g/h (0.42 g/day/g SP).
Collapse
Affiliation(s)
- Peng Li
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States.
| | - Henry Yip
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States.
| | - Dawn Sun
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States
| | - James Kempson
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States
| | - Janet Caceres-Cortes
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States
| | - Arvind Mathur
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States
| | - Dauh-Rurng Wu
- Department of Discovery Synthesis, Research and Early Development, Bristol Myers Squibb, Princeton, New Jersey, 08540, United States
| |
Collapse
|
4
|
Mishra B, Murthy G, Sahoo B, Uhm SJ, Gupta MK. Combinatorial ethanol treatment increases the overall productivity of recombinant hG-CSF in E. coli: a comparative study. Appl Microbiol Biotechnol 2020; 104:9135-9145. [PMID: 32945902 DOI: 10.1007/s00253-020-10899-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2020] [Revised: 09/03/2020] [Accepted: 09/08/2020] [Indexed: 12/22/2022]
Abstract
Human granulocyte colony-stimulating factor (hG-CSF) is a cytokine that regulates the proliferation, maturation, and differentiation of precursor cells to neutrophils. In the present study, we report the feasibility of inducing recombinant hG-CSF expression (rhG-CSF) in a pET vector system by combinatorial induction using low-concentration ethanol, IPTG, and lactose and auto-induction media (AIM). The coding sequence of hG-CSF transcript variant 2 was expressed in pET14 vector, and the effect of combinatorial induction was analyzed on inclusion body (IB) formation, biomass, protein purification, and bioactivity. Results showed that there was an inverse relationship between the temperature and soluble expression of rhG-CSF. Three-step washing with Triton-X, 2 M, and 5 M urea resulted in the maximum recovery of IBs. Combinatorial single-spike induction with IPTG, ethanol, and lactose in a batch culture led to a 3-fold increase in the expression of rhG-CSF. It was also observed that low concentration of ethanol (1-3% v/v) could be used in lieu of IPTG for inducing the rhG-CSF protein expression without adversely affecting biomass production. A 2.4-fold increase in productivity was obtained in LB-AIM media with combinatorial ethanol induction, and the overall yield of 2.8 g/L rhG-CSF was found. The purified rhG-CSF was bioactive and increased the cellular proliferation of umbilical cord blood-derived mesenchymal stem cells (U-MSC) by 29%. In conclusion, our study shows that combined ethanol induction can enhance the expression of rhG-CSF with three-step washing for recovery of the proteins from IBs and a single-step purification of rhG-CSF by affinity chromatography. KEY POINTS: • Low concentration of ethanol (1-3%) could be used in lieu of IPTG for inducing rhG-CSF expression. • Combinatorial single-spike induction with IPTG, ethanol, and lactose improved rhG-CSF expression. • Purified rhG-CSF was bioactive and increased the proliferation of U-MSC.
Collapse
Affiliation(s)
- Balaram Mishra
- Gene Manipulation Laboratory, Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Rourkela, Odisha, 769008, India
| | - Giridharan Murthy
- Gene Manipulation Laboratory, Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Rourkela, Odisha, 769008, India
| | - Bijayalaxmi Sahoo
- Gene Manipulation Laboratory, Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Rourkela, Odisha, 769008, India
| | - Sang Jun Uhm
- Department of Animal Science, Sangji University, Wonju, 26339, South Korea
| | - Mukesh Kumar Gupta
- Gene Manipulation Laboratory, Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Rourkela, Odisha, 769008, India.
| |
Collapse
|